Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Adherence To Treatment Guidelines Improves Early Breast Cancer Survival


The first study to compare survival between women with breast cancer whose treatment was based on consensus guidelines and those whose treatment was not shows that adhering to established guidelines improves survival and reduces the risk of recurrence. The study retrospectively examined whether the systemic therapy prescribed after surgery for women with early-stage breast cancer was consistent with treatment guidelines established for at the time. Systemic therapy includes chemotherapy and hormonal therapy and is designed to reach cancer cells that may have spread beyond the original tumor site. The study and an accompanying editorial will be published online August 2 in the Journal of Clinical Oncology (JCO) at

Using medical records from Canada’s national health care system, Dr. Hébert-Croteau and her colleagues compared survival between 1,002 women with early breast cancer whose systemic treatment was delivered according to guidelines developed at the 1992 St-Gallen conference in Switzerland, and 380 women whose treatment differed from those guidelines. The study also included 159 women whose guideline adherence was unknown. The women were diagnosed between 1988 and 1994 with invasive breast cancer that had not spread to nearby lymph nodes.

Developed by consensus with input from oncologists in Europe and North America, the St-Gallen guidelines continue to be updated regularly and are considered among the best guidelines available. The guidelines stipulate whether a woman with node-negative breast cancer should, after surgery, receive tamoxifen, chemotherapy, neither (as is the case for women at low risk of recurrence), or both, depending on her risk.

Researchers found that overall survival at 7 years was better among women whose systemic treatment complied with guidelines, especially for those at moderate risk of recurrence. Among those patients with moderate risk of recurrence, the 7-year survival was 88% for women who received treatment consistent with guideline recommendations vs. 79% among those whose therapy did not.

In addition, more women whose treatment differed from treatment guidelines experienced recurrence by 7 years than those whose therapy adhered to the guidelines. For those at moderate and high risk of recurrence, the recurrence rate at 7 years was 36% and 42% respectively when treatment did follow guidelines, versus 17% and 36% when treatment followed guidelines.

“Women treated for node-negative breast cancer according to consensus recommendations for systemic therapy experience a significant improvement in survival at 7 years,” said Nicole Hébert-Croteau, MD, PhD, Physician-Epidemiologist at the Quebec National Institute of Public Health and lead author of the study. “Our associations support the current movement for developing, updating, and disseminating such recommendations.”

Underuse of systemic therapy exists to some degree –at any cancer center – due to the complex nature of cancer care. For example, when a patient’s baseline prognosis is good, a physician may elect not to prescribe systemic therapy in efforts to avoid toxic side effects. Dr. Hébert-Croteau noted that patients may also have other medical problems that might influence the treatment recommendation.

An accompanying editorial by Rebecca A. Silliman, MD, PhD, of Boston University Medical Center notes that translating clinical guidelines into practice is often a slow and complex process. She suggests that interventions that use small-group, case-based approaches that incorporate role-playing and discussion are needed to change provider behaviors.

“Although evidence-based guidelines are a necessary beginning, they are not sufficient in and of themselves to change practice,” Dr. Silliman said. “What is required is a much more comprehensive approach that incorporates not only knowledge, but also builds skills and affects attitudes.”

Dr. Silliman noted that the results of this study should be interpreted with caution, since they pertain to medical care that was delivered more than a decade ago.

"Compliance with Consensus Recommendations for Systemic Therapy Is Associated with Improved Survival of Women with Node-Negative Breast Cancer.” Nicole Hébert-Croteau, et al, Quebec National Institute of Public Health, Montreal, Canada.

| newswise
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>